L. G. Oliveira, “Pathologic complete response and efficacy with neoadjuvant anthracycline followed by paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer: A real-world experience of Brazil”, MAST, vol. 33, no. suppl.1, Mar. 2026.